Prager Laura M, Wain John C, Roberts David H, Ginns Leo C
Lung Transplant Program, Massachusetts General Hospital, Boston, Massachusetts; Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
J Heart Lung Transplant. 2006 Oct;25(10):1206-12. doi: 10.1016/j.healun.2006.06.014.
Living donor lobar lung transplantation is a viable therapy for carefully selected patients with end-stage pulmonary disease. Its success is largely dependent upon donor outcome, including both physical and emotional factors. To date, there has been little focus on psychosocial outcomes of lobar lung donors.
Retrospective evaluation of 15 of 20 living lobar lung transplant donors was performed. Donors underwent evaluation of pulmonary function after recovery from donor lobectomy. Participants completed two self-report questionnaires, the SF-36 Health Survey (SF-36) and the Beck Depression Inventory (BDI), as well as an open-ended psychiatric interview.
After lobar donation, mean forced expiratory volume in 1 second (FEV(1)) decreased by 21 +/- 2%, forced vital capacity (FVC) decreased by 16 +/- 3%, total lung capacity (TLC) decreased by 15 +/- 3%, and single-breath diffusing capacity (DLCO) decreased by 14 +/- 4%. All subjects scored higher than the national average on both the physical and mental health components of the SF-36. The BDI scores showed no evidence of clinical depression. However, the subjective interviews elicited two common complaints: (1) a decline in exercise performance, not accounted for by resting lung function measurements; and (2) a dissatisfaction with the degree of acknowledgment of their donation.
Living lobar lung transplant donors enjoy generally satisfactory physical and emotional health. Donors report positive feelings about donation, but wish to be recognized and valued by the transplant team and by the recipient. Despite preservation of lung function within the normal range, some donors also experience a subjective decline in exercise tolerance. Long-term medical and psychologic follow-up appears warranted to monitor symptoms of exercise impairment and to enhance the donor experience.
活体供者肺叶移植是一种针对精心挑选的终末期肺病患者的可行治疗方法。其成功很大程度上取决于供者的结局,包括身体和情感因素。迄今为止,很少关注肺叶供者的心理社会结局。
对20例活体肺叶移植供者中的15例进行回顾性评估。供者在供者肺叶切除术后恢复过程中接受肺功能评估。参与者完成了两份自我报告问卷,即SF-36健康调查(SF-36)和贝克抑郁量表(BDI),以及一次开放式精神科访谈。
肺叶捐赠后,平均一秒用力呼气量(FEV(1))下降了21±2%,用力肺活量(FVC)下降了16±3%,肺总量(TLC)下降了15±3%,单次呼吸弥散量(DLCO)下降了14±4%。所有受试者在SF-36的身心健康分量表上的得分均高于全国平均水平。BDI评分未显示临床抑郁的迹象。然而,主观访谈引出了两个常见的抱怨:(1)运动表现下降,静息肺功能测量无法解释;(2)对其捐赠的认可程度不满意。
活体肺叶移植供者的身心健康总体上令人满意。供者对捐赠有积极的感受,但希望得到移植团队和受者的认可和重视。尽管肺功能保持在正常范围内,但一些供者也主观感觉运动耐量下降。长期的医学和心理随访似乎有必要,以监测运动功能受损的症状并改善供者的体验。